VANGUARD RESEARCH GROUP
NEWSLETTER
June 2023
MAY 20TH WAS CLINICAL TRIALS DAY!
Clinical Trials have brought us all together to advance treatment options, so let’s take a moment to celebrate our work!
This year, we want to highlight Cochrane’s work on advocating for Clinical Trial Transparency. If you are new to research or have not worked with systematic reviews, the link also offers a great video-based explanation of what systematic reviews are:
AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY (ASCP)
The ASCP annual meeting was just held May 31st through June 2nd. If you were unable to attend, below is a link to the abstracts and posters that were presented at the meeting. There is a lot of great research being conducted, so check out the link to learn more.
https://pmg.joynadmin.org/documents/1005/628e68149557aa5a02655c33.pdf
WE HAVE CURRENT PROJECTS SEEKING ADDITIONAL SITES!
A novel pharmacological treatment for cognitive impairment for schizophrenia patients
An observational study to evaluate the clinical course and treatment of tardive dyskinesia (TD).
o Questionnaires to assess the impact of TD on quality of life, sites and clients are reimbursed to participate
A survey To evaluate clients’ opinions on the difficulty of completing basic health care tasks
o Clients will be asked to rate their difficulty in completing 11 basic tasks
o Site participant data will be anonymized and returned to the site along with cumulative data for all participants
If you are interested in learning more or participating, please email Ben George at bgeorge7@northwell.edu.
FOLLOW US ON SOCIAL MEDIA
DOWNLOAD PDF.